Nanocurie to Millicurie

Receptor binding assays are the classic example. A biochemist adds 2–5 nCi of tritium-labelled drug to a plate of cells and measures how much binds to a receptor versus washing away. Metabolic tracing studies use similar amounts of carbon-14-labelled glucose or amino acids to follow biochemical pathways. At nanocurie levels the radioactivity is low enough that bench work requires minimal shielding — a few centimeters of acrylic for tritium beta particles — but high enough to produce a detectable signal after hours of counting.

One nanocurie equals 37 Bq — about the activity of 2.5 bananas worth of potassium-40, or roughly 0.5% of the natural K-40 activity in your own body. A smoke detector contains about 30,000 nCi (1 µCi) of americium. The nanocurie sits in the gap between environmental levels you cannot avoid (picocuries) and laboratory quantities that require formal licensing (microcuries). It is the unit of "detectable but not dangerous," which is exactly why it suits low-level lab work.

Tritium (hydrogen-3) is the perfect biological tracer because hydrogen appears in every organic molecule. You can replace a hydrogen atom with tritium without changing the molecule's chemistry — the drug, amino acid, or sugar behaves identically in the cell. Tritium emits only very low-energy beta particles (max 18.6 keV) that cannot penetrate skin or even a lab bench surface, making it the safest radioisotope to handle. The downside is low specific activity, so you need sensitive liquid scintillation counting to detect it — but at nanocurie levels, that is perfectly adequate.

In the US, NRC exempt quantities vary by isotope. For tritium, the exempt quantity is 1,000 µCi (1 mCi); for carbon-14 it is 100 µCi; for iodine-125 it is just 1 µCi. Nanocurie-scale quantities are generally below exempt limits for most isotopes, but universities and companies typically hold broad licenses covering all their work anyway. The license requirements are not about the activity alone — they are about accountability, training, waste disposal, and ensuring that small amounts do not accumulate into large ones through careless stockpiling.

For short-lived isotopes (half-life under 120 days), most institutions use "decay in storage" — the waste sits in a shielded cabinet for 10 half-lives until it is indistinguishable from background, then gets disposed of as normal chemical waste with all radioactive labels removed. For longer-lived isotopes like tritium (12.3-year half-life) or carbon-14 (5,730 years), the waste is collected in designated containers, catalogd by isotope and activity, and shipped to a licensed low-level radioactive waste broker. At nanocurie levels the volumes are small, so the main cost is paperwork, not shielding.

Yes, and it creates real problems. If a patient who received therapeutic I-131 (30–200 mCi) dies within days, the body can trigger radiation alarms at funeral homes and crematoria. Cremation is the bigger concern — burning the body aerosolises the isotope, contaminating the crematorium and potentially exposing workers. Most radiation safety programs require a waiting period before cremation, or direct burial with notification to the funeral director. In 2019, an Arizona crematorium unknowingly cremated a patient with residual lutetium-177, contaminating the facility. Hospitals are supposed to flag these cases, but the system is imperfect.

The radiopharmacist draws the Tc-99m solution into a syringe, places it in a dose calibrator (a pressurized argon ionisation chamber), and reads the activity in mCi or MBq. Because the isotope is decaying constantly — Tc-99m loses half its activity every 6 hours — the calibrator reading must be decay-corrected to the planned injection time. If the scan is at 2pm and the dose is drawn at 10am, the pharmacist dispenses more than the prescribed 20 mCi, knowing it will decay to exactly 20 mCi by injection. Timing is everything.

The Tc-99m bone scan, with about 20–25 mCi (740–925 MBq) injected intravenously. Technetium-99m accumulates in areas of high bone turnover — fractures, infections, metastases — and emits 140 keV gamma rays that a gamma camera images. The scan itself takes 2–3 hours (allowing time for the tracer to distribute), and the patient's radioactivity drops to negligible levels within 24–48 hours. Over 30 million Tc-99m procedures are performed worldwide each year, making it by far the most-used medical radioisotope.

Technically yes, but radiation detectors at airports, borders, and government buildings may alarm for days after certain scans. A patient who received 10 mCi of I-131 can trigger a portal monitor for up to 3 months. Most nuclear medicine departments provide a wallet card explaining the procedure, isotope, and date — TSA and customs agents are trained to recognize these. The actual radiation risk to fellow passengers is negligible; the issue is entirely about security system sensitivity, not safety.

Hyperthyroidism treatment aims to kill just enough thyroid tissue to normalize hormone production — typically 5–15 mCi (185–555 MBq) of I-131. Thyroid cancer ablation aims to destroy every remaining thyroid cell after surgery and kill any metastases — that takes 30–200 mCi (1.1–7.4 GBq). The higher doses require inpatient isolation and more aggressive radiation safety precautions. Some oncologists are exploring whether lower ablation doses (30 mCi) work as well as high ones (100+ mCi) for low-risk cancers — the evidence is surprisingly close.